{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:08:29Z","timestamp":1789106909448,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Denosumab is a potent RANKL inhibitor used for osteoporosis, yet its impact on root canal treatment (RCT) outcomes remains less understood compared to bisphosphonates. This study evaluated the periapical healing outcomes of RCT in patients receiving denosumab and identified clinical variables influencing treatment success.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective case-control study included 20 patients with osteoporosis receiving denosumab who underwent RCT at a major tertiary hospital between July 2014 and June 2024 (group D), along with 20 age- and sex-matched systemically healthy controls (group C). Among 116 denosumab-treated patients screened, 20 met the strict selection criteria and were enrolled as the study group. Periapical healing was assessed using the Periapical Index (PAI) at a minimum follow-up of 3 months after treatment. Various clinical and radiographic factors, including initial PAI scores and sealer extrusion, were analyzed using logistic regression to determine their impact on healing rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median follow-up period was 534 (287\u2013956) days for group D and 421 (235\u20131045) days for group C. The overall periapical healing rates were 75.0.% in the denosumab group and 90.0% in the healthy control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.407). Multivariable logistic regression analysis did not identify any statistically significant predictors of healing outcomes. However, higher initial PAI scores (OR\u2009=\u20097.610,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.088) and sealer extrusion (OR\u2009=\u20093.70,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.185) were associated with less favorable outcomes in the multivariable model. Sealer extrusion was significantly associated with healing outcomes in univariate analysis (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.034).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Within the limitations of this study, there was no statistically significant difference in the proportion of healed cases between patients receiving denosumab therapy and healthy controls. These findings suggest that non-surgical root canal treatment may remain a viable tooth-preserving treatment option for patients receiving denosumab therapy. Careful apical control and long-term follow-up may be particularly important in patients presenting with large pre-existing periapical lesions and sealer extrusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-026-09287-2","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T01:05:16Z","timestamp":1785719116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of denosumab therapy on periapical healing following root canal treatment: a 10-year retrospective case-control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Bokyung","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Jee","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Jun","family":"Shon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"Suppl 2","key":"9287_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/iej.13897","volume":"56","author":"K Gulabivala","year":"2023","unstructured":"Gulabivala K, Ng YL. Factors that affect the outcomes of root canal treatment and retreatment-a reframing of the principles. Int Endod J. 2023;56(Suppl 2):82\u2013115.","journal-title":"Int Endod J"},{"issue":"3","key":"9287_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.joen.2007.10.017","volume":"34","author":"C de Chevigny","year":"2008","unstructured":"de Chevigny C, Dao TT, Basrani BR, Marquis V, Farzaneh M, Abitbol S, et al. Treatment outcome in endodontics: the Toronto study\u2013phase 4: initial treatment. J Endod. 2008;34(3):258\u201363.","journal-title":"J Endod"},{"issue":"1","key":"9287_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-9657.1986.tb00119.x","volume":"2","author":"D Orstavik","year":"1986","unstructured":"Orstavik D, Kerekes K, Eriksen HM. The periapical index: a scoring system for radiographic assessment of apical periodontitis. Endod Dent Traumatol. 1986;2(1):20\u201334.","journal-title":"Endod Dent Traumatol"},{"issue":"1","key":"9287_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/prd.12422","volume":"89","author":"B Yu","year":"2022","unstructured":"Yu B, Wang CY. Osteoporosis and periodontal diseases - an update on their association and mechanistic links. Periodontol 2000. 2022;89(1):99\u2013113.","journal-title":"Periodontol 2000"},{"issue":"5","key":"9287_CR5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/cre2.604","volume":"8","author":"E Cadoni","year":"2022","unstructured":"Cadoni E, Ideo F, Marongiu G, Mezzena S, Frigau L, Mela Q, et al. Periapical status in patients affected by osteoporosis: a retrospective clinical study. Clin Exp Dent Res. 2022;8(5):1068\u201375.","journal-title":"Clin Exp Dent Res"},{"issue":"1","key":"9287_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S, et al. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021;16(1):609.","journal-title":"J Orthop Surg Res"},{"issue":"5","key":"9287_CR7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American association of oral and maxillofacial surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 Update. J Oral Maxillofac Surg. 2022;80(5):920\u201343.","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"9287_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/iej.12018","volume":"46","author":"AT Moinzadeh","year":"2013","unstructured":"Moinzadeh AT, Shemesh H, Neirynck NA, Aubert C, Wesselink PR. Bisphosphonates and their clinical implications in endodontic therapy. Int Endod J. 2013;46(5):391\u20138.","journal-title":"Int Endod J"},{"issue":"3","key":"9287_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1747-4477.2010.00280.x","volume":"36","author":"A Kyrgidis","year":"2010","unstructured":"Kyrgidis A, Arora A, Lyroudia K, Antoniades K. Root canal therapy for the prevention of osteonecrosis of the jaws: an evidence-based clinical update. Aust Endod J. 2010;36(3):130\u20133.","journal-title":"Aust Endod J"},{"issue":"2","key":"9287_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/iej.13405","volume":"54","author":"F Zamparini","year":"2021","unstructured":"Zamparini F, Pelliccioni GA, Spinelli A, Gissi DB, Gandolfi MG, Prati C. Root canal treatment of compromised teeth as alternative treatment for patients receiving bisphosphonates: 60-month results of a prospective clinical study. Int Endod J. 2021;54(2):156\u201371.","journal-title":"Int Endod J"},{"issue":"4","key":"9287_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1055\/s-0044-1785533","volume":"18","author":"E Stanev","year":"2024","unstructured":"Stanev E, Vasileva RI. Influence of osteoporosis on the course of apical periodontitis. Eur J Dent. 2024;18(4):997\u20131003.","journal-title":"Eur J Dent"},{"issue":"4","key":"9287_CR12","doi-asserted-by":"publisher","first-page":"105883","DOI":"10.1016\/j.jbspin.2025.105883","volume":"92","author":"F Tilotta","year":"2025","unstructured":"Tilotta F, Gosset M, Herrou J, Briot K, Roux C. Association between osteoporosis and periodontitis. Joint Bone Spine. 2025;92(4):105883.","journal-title":"Joint Bone Spine"},{"issue":"2","key":"9287_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2591.2012.02105.x","volume":"46","author":"GN Belibasakis","year":"2013","unstructured":"Belibasakis GN, Rechenberg DK, Zehnder M. The receptor activator of NF-\u03baB ligand-osteoprotegerin system in pulpal and periapical disease. Int Endod J. 2013;46(2):99\u2013111.","journal-title":"Int Endod J"},{"issue":"4","key":"9287_CR14","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s10266-024-00911-7","volume":"112","author":"Q Wang","year":"2024","unstructured":"Wang Q, Wang L, Sheng L, Zhang B, Jieensi B, Zheng S, et al. Correlation between PD-1\/PD-L1 and RANKL\/OPG in chronic apical periodontitis model of Sprague-Dawley rats. Odontology. 2024;112(4):1113\u201322.","journal-title":"Odontology"},{"issue":"4","key":"9287_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/jbmr.2097","volume":"29","author":"TL Aghaloo","year":"2014","unstructured":"Aghaloo TL, Cheong S, Bezouglaia O, Kostenuik P, Atti E, Dry SM, et al. RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease. J Bone Min Res. 2014;29(4):843\u201354.","journal-title":"J Bone Min Res"},{"issue":"5","key":"9287_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41584-023-00935-3","volume":"19","author":"S Ferrari","year":"2023","unstructured":"Ferrari S, Langdahl B. Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone. Nat Rev Rheumatol. 2023;19(5):307\u201317.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"9287_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd3705","volume":"11","author":"DL Lacey","year":"2012","unstructured":"Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, et al. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov. 2012;11(5):401\u201319.","journal-title":"Nat Rev Drug Discov"},{"issue":"16","key":"9287_CR18","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.18632\/oncotarget.2160","volume":"5","author":"A Schieferdecker","year":"2014","unstructured":"Schieferdecker A, Voigt M, Riecken K, Braig F, Schinke T, Loges S, et al. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. Oncotarget. 2014;5(16):6647\u201353.","journal-title":"Oncotarget"},{"issue":"3","key":"9287_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/00016357.2018.1521005","volume":"77","author":"PH Braz-Silva","year":"2019","unstructured":"Braz-Silva PH, Bergamini ML, Mardegan AP, De Rosa CS, Hasseus B, Jonasson P. Inflammatory profile of chronic apical periodontitis: a literature review. Acta Odontol Scand. 2019;77(3):173\u201380.","journal-title":"Acta Odontol Scand"},{"issue":"5","key":"9287_CR20","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cell.2021.02.002","volume":"184","author":"MM McDonald","year":"2021","unstructured":"McDonald MM, Khoo WH, Ng PY, Xiao Y, Zamerli J, Thatcher P, et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell. 2021;184(5):1330\u2013e4713.","journal-title":"Cell"},{"issue":"4","key":"9287_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RG. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 2011;48(4):677\u201392.","journal-title":"Bone"},{"issue":"11","key":"9287_CR22","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.joen.2016.07.020","volume":"42","author":"M Song","year":"2016","unstructured":"Song M, Alshaikh A, Kim T, Kim S, Dang M, Mehrazarin S, et al. Preexisting periapical inflammatory condition exacerbates tooth extraction-induced bisphosphonate-related osteonecrosis of the jaw lesions in mice. J Endod. 2016;42(11):1641\u20136.","journal-title":"J Endod"},{"issue":"5","key":"9287_CR23","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/iej.14207","volume":"58","author":"CF Lopes","year":"2025","unstructured":"Lopes CF, Pinto KP, Ferreira CMA, de Souza JB, Lopes RT, Alves A, et al. The risk of osteonecrosis after apical patency during antiresorptive therapy in an animal model. Int Endod J. 2025;58(5):776\u201386.","journal-title":"Int Endod J"},{"issue":"1","key":"9287_CR24","first-page":"87","volume":"14","author":"H Ga\u00eata-Araujo","year":"2021","unstructured":"Ga\u00eata-Araujo H, Ferreira Leite A, de Faria Vasconcelos K, Coropciuc R, Politis C, Jacobs R, et al. Why do some extraction sites develop medication-related osteonecrosis of the jaw and others do not? a within-patient study assessing radiographic predictors. Int J Oral Implantol (Berl). 2021;14(1):87\u201398.","journal-title":"Int J Oral Implantol (Berl)"},{"issue":"1","key":"9287_CR25","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1186\/s12903-025-06741-5","volume":"25","author":"R Mauceri","year":"2025","unstructured":"Mauceri R, Coppini M, Caponio VCA, Zamparini F, Prati C, Campisi G. Endodontic therapy and Medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis. BMC Oral Health. 2025;25(1):1362.","journal-title":"BMC Oral Health"},{"issue":"11","key":"9287_CR26","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.joen.2009.07.020","volume":"35","author":"A Hsiao","year":"2009","unstructured":"Hsiao A, Glickman G, He J. A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates. J Endod. 2009;35(11):1525\u20138.","journal-title":"J Endod"},{"issue":"10329","key":"9287_CR27","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","volume":"399","author":"IR Reid","year":"2022","unstructured":"Reid IR, Billington EO. Drug therapy for osteoporosis in older adults. Lancet. 2022;399(10329):1080\u201392.","journal-title":"Lancet"},{"issue":"4","key":"9287_CR28","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.5395\/rde.2019.44.e42","volume":"44","author":"M Song","year":"2019","unstructured":"Song M. Dental care for patients taking antiresorptive drugs: a literature review. Restor Dent Endod. 2019;44(4):e42.","journal-title":"Restor Dent Endod"},{"issue":"8","key":"9287_CR29","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1111\/jgs.18414","volume":"71","author":"B Boston","year":"2023","unstructured":"Boston B, Ipe D, Capitanescu B, Gresita A, Hamlet S, Love R, et al. Medication-related osteonecrosis of the jaw: a disease of significant importance for older patients. J Am Geriatr Soc. 2023;71(8):2640\u201352.","journal-title":"J Am Geriatr Soc"},{"key":"9287_CR30","volume-title":"AAE position statement: endodontic implications of medication-related osteonecrosis of the jaw","author":"American association of endodontists","year":"2018","unstructured":"American association of endodontists. AAE position statement: endodontic implications of medication-related osteonecrosis of the jaw. Chicago, IL: American association of endodontists; 2018."}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-09287-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-09287-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-09287-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:42:46Z","timestamp":1789105366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-09287-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9287"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-09287-2","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board (IRB) of Seoul National University Bundang Hospital (SNUBH) (IRB No. B-2408-919-102). The requirement for informed consent was waived by the Institutional Review Board of Seoul National University Bundang Hospital due to the retrospective nature of the study and the use of de-identified data. All procedures were performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1708"}}